May 15, 2024: Congratulations to Dr. Katie Ryan on her recent publication in Biorganic & Medicinal Chemistry entitled “Discovery of 9H-pyrimido[4,5-b]indole derivatives as dual RET/TRKA inhibitors” . In this study, Dr. Ryan and her collaborator, Dr. Brendan Frett (an RPL on Dr. Boerma’s COBRE), developed dual RET/TRK inhibitors with potential applications targeting aberrant signaling mechanisms of multiple, treatment resistant cancers. This was the first publication to cite the CMIC award P20 GM152281. So, a big “THANK YOU!!!” to Dr. Ryan and her team for citing our COBRE.